Quest, Hologic Sign Five-Year Deal on Women’s Diagnostics

Hologic and Quest Diagnostics have struck a five-year deal for Quest to offer a broader range of women’s health testing based on Hologic’s APTIMA products. These include assays for HPV, chlamydia, gonorrhea and trichomonas vaginalis. Quest will continue using Hologic’s ThinPrep cytology products and offering the APTIMA HPV mRNA-based assay as well.
Devices & Diagnostics Letter